Document is current
Any future updates will be listed below
-
Authors
Lee, Andie S.
de Lencastre, Hermínia
Garau, Javier
Kluytmans, Jan
Malhotra-Kumar, Surbhi
Peschel, Andreas
Harbarth, Stephan
- License Information
-
More Information
Article History
First Online: 31 May 2018
Competing interests
: J.G. has acted as a consultant for Roche, Nabriva, Paratek and Menarini. J.K. acts as a consultant for Pfizer, 3M and Destiny Pharma. S.M.-K. has received grants from Abbott and Agfa Health. She is receiving research grants from Pfizer and Huvepharma and has a service agreement with AiCuris. A.P. receives a consultant fee from Crucell and research grants from Crucell, Medimmune, MorphoSys and Roche; he has a patent pending for lugdunin. S.H. was a temporary member of the speakers’ bureau for Takeda; has participated in the scientific advisory boards of DNA Electronics, Sandoz, GlaxoSmithKline and Bayer; and has received financial support for research activities from Pfizer and B. Braun. A.S.L. and H.d.L. declare no conflicts of interest.
